Novel first-dose adverse drug reactions during a phase I trial of olipudase alfa (recombinant human acid sphingomyelinase) in adults with Niemann-Pick disease type B (acid sphingomyelinase deficiency)

Margaret M. McGovern, Melissa P. Wasserstein, Brian Kirmse, W. Lane Duvall, Thomas Schiano, Beth L. Thurberg, Susan Richards, Gerald F. Cox

Research output: Contribution to journalArticle

22 Scopus citations

Fingerprint Dive into the research topics of 'Novel first-dose adverse drug reactions during a phase I trial of olipudase alfa (recombinant human acid sphingomyelinase) in adults with Niemann-Pick disease type B (acid sphingomyelinase deficiency)'. Together they form a unique fingerprint.

Medicine & Life Sciences